| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.05. | AngioDynamics wins CE Mark for AlphaVac F18 | 1 | MassDevice | ||
| 22.05. | AngioDynamics' (ANGO) AlphaVac System Gets CE Mark Approval | 1 | Zacks | ||
| 22.05. | AngioDynamics receives CE Mark approval in Europe for AlphaVac F1885 System | 1 | Seeking Alpha | ||
| 21.05. | AngioDynamics, Inc.: AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F1885 System | 262 | Business Wire | Regulatory approval enables entry of AlphaVac Mechanical Thrombectomy System in European market
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused... ► Artikel lesen | |
| 09.04. | ANGIODYNAMICS INC - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 08.04. | AngioDynamics, Inc. (ANGO) Q3 2024 Earnings Call Transcript | 1 | Insider Monkey | ||
| 08.04. | Earnings call: AngioDynamics posts mixed Q3 results, focuses on growth | 1 | Investing.com | ||
| 05.04. | AngioDynamics (ANGO) Q3 Earnings and Revenues Miss Estimates | 3 | Zacks | ||
| 05.04. | AngioDynamics' (ANGO) AlphaVac Gets FDA Nod for PE Treatment | 1 | Zacks | ||
| 05.04. | AngioDynamics upgraded at Oppenheimer on pipeline progress | 1 | Seeking Alpha | ||
| 05.04. | FDA clears AngioDynamics' AlphaVac F18 to treat pulmonary embolism | 2 | MassDevice | ||
| 04.04. | Medical Devices Focused AngioDynamics Unveils Upbeat 2024 Financial Outlook, Stock Soars | 1 | Benzinga.com | ||
| 04.04. | AngioDynamics Q3 Loss Sharply Widens; Slashes FY24 Outlook | 1 | RTTNews | ||
| 04.04. | AngioDynamics gets FDA clearance for pulmonary embolism treatment device | 2 | Seeking Alpha | ||
| 04.04. | ANGIODYNAMICS INC - 8-K, Current Report | 1 | SEC Filings | ||
| 04.04. | AngioDynamics: FDA Clears AlphaVac F1885 System In Treatment Of Pulmonary Embolism | 1 | RTTNews | ||
| 04.04. | AngioDynamics Non-GAAP EPS of -$0.16, revenue of $65.97M | 1 | Seeking Alpha | ||
| 04.04. | AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture | 141 | Business Wire | LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO):
Fiscal Year 2024 Third Quarter Highlights
Completed the sale of its PICC and Midline product portfolios to Spectrum Vascular... ► Artikel lesen | |
| 03.04. | AngioDynamics Q3 2024 Earnings Preview | 1 | Seeking Alpha | ||
| 02.04. | AngioDynamics settles patent litigations with BD's Bard | 4 | MassDevice |
Seite:
1 2 3 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NEL | 500 |
| NVIDIA | 404 |
| EVOTEC | 397 |
| BIONTECH | 294 |
| TUI | 260 |
| BAYER | 257 |
| VOLKSWAGEN | 202 |
| PLUG POWER | 194 |
| GAMESTOP | 188 |
| RHEINMETALL | 183 |
| BYD | 152 |
| SALESFORCE | 137 |
| DELL TECHNOLOGIES | 113 |
| BASF | 109 |
| AIXTRON SE | 107 |
| DEUTSCHE LUFTHANSA | 103 |
| MERCEDES-BENZ | 100 |
| TESLA | 98 |
| SUPER MICRO COMPUTER | 91 |
| DEUTSCHE TELEKOM | 89 |
| AMAZON | 85 |
| NIO INC ADR | 85 |
| MICROSOFT | 83 |
| SIEMENS ENERGY | 82 |
| DEUTSCHE BANK | 77 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
